Patient-Square-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "INSM",
  "ALLO",
  "MIRM",
  "LQDA",
  "NRIX",
  "KYMR",
  "PHVS",
  "SRRK",
  "AGIO",
  "NTLA",
  "SLNO",
  "ROIV",
  "ELVN",
  "EYPT",
  "VYNE",
  "BPMC",
  "CGEM",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 19
Total Value: 241723318
Accession Number: 0000950123-25-005195
Form Type: 13F-HR
CIK: patient-square-capital-lp
Manager Name: Patient-Square-Capital-Lp

Data Enrichment

100% identified

19 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

19 positions • $241.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Roivant Sciences Ltd.

ROIV|G76279101

Shares:12.5M

Value:$125.9M

% of Portfolio:52.1% ($125.9M/$241.7M)

INSMED Inc

INSM|457669307

Shares:330.3K

Value:$25.2M

% of Portfolio:10.4% ($25.2M/$241.7M)

Liquidia Corp

LQDA|53635D202

Shares:1.5M

Value:$22.5M

% of Portfolio:9.3% ($22.5M/$241.7M)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:1.5M

Value:$8.0M

% of Portfolio:3.3% ($8.0M/$241.7M)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:920.2K

Value:$6.7M

% of Portfolio:2.8% ($6.7M/$241.7M)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:878.9K

Value:$6.7M

% of Portfolio:2.8% ($6.7M/$241.7M)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:447.3K

Value:$5.3M

% of Portfolio:2.2% ($5.3M/$241.7M)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:116.4K

Value:$5.2M

% of Portfolio:2.2% ($5.2M/$241.7M)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:253.8K

Value:$5.0M

% of Portfolio:2.1% ($5.0M/$241.7M)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:154.0K

Value:$5.0M

% of Portfolio:2.0% ($5.0M/$241.7M)

Disc Medicine, Inc.

IRON|254604101

Shares:83.0K

Value:$4.1M

% of Portfolio:1.7% ($4.1M/$241.7M)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:139.7K

Value:$4.1M

% of Portfolio:1.7% ($4.1M/$241.7M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:142.2K

Value:$3.9M

% of Portfolio:1.6% ($3.9M/$241.7M)

Pharvaris N.V.

PHVS|N69605108

Shares:245.5K

Value:$3.9M

% of Portfolio:1.6% ($3.9M/$241.7M)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:2.4M

Value:$3.5M

% of Portfolio:1.4% ($3.5M/$241.7M)

Blueprint Medicines Corp

BPMC|09627Y109

Shares:38.5K

Value:$3.4M

% of Portfolio:1.4% ($3.4M/$241.7M)

Intellia Therapeutics, Inc.

NTLA|45826J105

Shares:232.8K

Value:$1.7M

% of Portfolio:0.7% ($1.7M/$241.7M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:18.6K

Value:$1.3M

% of Portfolio:0.5% ($1.3M/$241.7M)

VYNE Therapeutics Inc.

VYNE|92941V308

Shares:257.0K

Value:$406.1K

% of Portfolio:0.2% ($406.1K/$241.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Roivant Sciences Ltd.(ROIVcusipG76279101)	12.5M	QoQ 0.00% (-0) YoY +2.05% (-251.5K)	All Managers (Combined)	$125.9M	52.1% ($125.9M/$241.7M)	QoQ -14.70% (-$21.7M) YoY -2.30% (-$3.0M)
INSMED Inc(INSMcusip457669307)	330.3K	QoQ +7.51% (+23.1K) YoY NEW(+330.3K)	All Managers (Combined)	$25.2M	10.4% ($25.2M/$241.7M)	QoQ +18.80% (+$4.0M) YoY NEW(+$25.2M)
Liquidia Corp(LQDAcusip53635D202)	1.5M	QoQ -18.16% (-337.9K) YoY -78.80% (-5.7M)	All Managers (Combined)	$22.5M	9.3% ($22.5M/$241.7M)	QoQ +2.64% (-$578.2K) YoY -78.80% (-$83.5M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	1.5M	QoQ +5.08% (-71.6K) YoY NEW(+1.5M)	All Managers (Combined)	$8.0M	3.3% ($8.0M/$241.7M)	QoQ -23.55% (-$2.5M) YoY NEW(+$8.0M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	920.2K	QoQ +95.40% (+449.3K) YoY NEW(+920.2K)	All Managers (Combined)	$6.7M	2.8% ($6.7M/$241.7M)	QoQ +67.71% (+$2.7M) YoY NEW(+$6.7M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	878.9K	QoQ 0.00% (-0) YoY NEW(+878.9K)	All Managers (Combined)	$6.7M	2.8% ($6.7M/$241.7M)	QoQ -37.84% (-$4.1M) YoY NEW(+$6.7M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	447.3K	QoQ +0.22% (-1.0K) YoY NEW(+447.3K)	All Managers (Combined)	$5.3M	2.2% ($5.3M/$241.7M)	QoQ -36.80% (-$3.1M) YoY NEW(+$5.3M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	116.4K	QoQ +79.29% (+51.5K) YoY NEW(+116.4K)	All Managers (Combined)	$5.2M	2.2% ($5.2M/$241.7M)	QoQ +95.33% (+$2.6M) YoY NEW(+$5.2M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	253.8K	QoQ +13.30% (-29.8K) YoY NEW(+253.8K)	All Managers (Combined)	$5.0M	2.1% ($5.0M/$241.7M)	QoQ -0.89% (-$45.3K) YoY NEW(+$5.0M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	154.0K	QoQ +381.25% (+122.0K) YoY NEW(+154.0K)	All Managers (Combined)	$5.0M	2.0% ($5.0M/$241.7M)	QoQ +257.98% (+$3.6M) YoY NEW(+$5.0M)
Disc Medicine, Inc.(IRONcusip254604101)	83.0K	QoQ +47.16% (+26.6K) YoY NEW(+83.0K)	All Managers (Combined)	$4.1M	1.7% ($4.1M/$241.7M)	QoQ +15.22% (+$544.4K) YoY NEW(+$4.1M)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	139.7K	QoQ +14.78% (+18.0K) YoY NEW(+139.7K)	All Managers (Combined)	$4.1M	1.7% ($4.1M/$241.7M)	QoQ +2.35% (+$94.0K) YoY NEW(+$4.1M)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	142.2K	QoQ NEW(+142.2K) YoY NEW(+142.2K)	All Managers (Combined)	$3.9M	1.6% ($3.9M/$241.7M)	QoQ NEW(+$3.9M) YoY NEW(+$3.9M)
Pharvaris N.V.(PHVScusipN69605108)	245.5K	QoQ +18.25% (-37.9K) YoY NEW(+245.5K)	All Managers (Combined)	$3.9M	1.6% ($3.9M/$241.7M)	QoQ -3.15% (-$125.5K) YoY NEW(+$3.9M)
Allogene Therapeutics, Inc.(ALLOcusip019770106)	2.4M	QoQ +58.94% (+878.3K) YoY NEW(+2.4M)	All Managers (Combined)	$3.5M	1.4% ($3.5M/$241.7M)	QoQ +8.95% (+$284.0K) YoY NEW(+$3.5M)
Blueprint Medicines Corp(BPMCcusip09627Y109)	38.5K	QoQ NEW(+38.5K) YoY NEW(+38.5K)	All Managers (Combined)	$3.4M	1.4% ($3.4M/$241.7M)	QoQ NEW(+$3.4M) YoY NEW(+$3.4M)
Intellia Therapeutics, Inc.(NTLAcusip45826J105)	232.8K	QoQ +7.77% (-16.8K) YoY NEW(+232.8K)	All Managers (Combined)	$1.7M	0.7% ($1.7M/$241.7M)	QoQ -34.27% (-$863.3K) YoY NEW(+$1.7M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	18.6K	QoQ NEW(+18.6K) YoY NEW(+18.6K)	All Managers (Combined)	$1.3M	0.5% ($1.3M/$241.7M)	QoQ NEW(+$1.3M) YoY NEW(+$1.3M)
VYNE Therapeutics Inc.(VYNEcusip92941V308)	257.0K	QoQ NEW(+257.0K) YoY NEW(+257.0K)	All Managers (Combined)	$406.1K	0.2% ($406.1K/$241.7M)	QoQ NEW(+$406.1K) YoY NEW(+$406.1K)